Turning the tide on Non-Alcohol Fatty Liver Disease
Posted on 27.04.2021
It is estimated that Non-Alcoholic Fatty Liver Disease (NAFLD) affects as many as one billion people worldwide. NAFLD can be prevented and reversed but if left untreated, can cause more serious conditions like cirrhosis and advanced fibrosis. A recently developed diagnostic solution offers a more patient-centric approach to the diagnosis, monitoring and treatment of this condition. This is the story of the innovators at the heart of this development, and the patients facing better health outcomes as a result.